Company news

ME Therapeutics Holdings, Inc. news in 2026

ME Therapeutics Holdings, Inc.'s news releases, calls and decks from 2026, newest first.

View company

ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset

October 9, 2026

ME Therapeutics Advances In Vivo CAR and Therapeutic mRNA STING Programs

September 8, 2026

ME Therapeutics Closes Over-Subscribed Private Placement

July 17, 2026

ME Therapeutics Announces Private Placement

June 3, 2026

ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver

May 7, 2026

ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs

April 29, 2026

ME Therapeutics Scientific and Corporate Update

January 30, 2026

ME Therapeutics Attending JP Morgan Healthcare Conference

January 6, 2026

Decks in 2026